Genetic risk factors for Mesoamerican nephropathy
- PMID: 39585978
- PMCID: PMC11626114
- DOI: 10.1073/pnas.2404848121
Genetic risk factors for Mesoamerican nephropathy
Abstract
Mesoamerican nephropathy (MeN) is a progressive kidney disease found on the Pacific coast of Central America primarily in young male agricultural workers without typical kidney disease risk factors. While it is generally accepted that environmental exposures contribute to MeN, we hypothesized that there was also an important genetic component. We performed a genome-wide association study comparing individuals with MeN versus individuals with normal kidney function. We found that Native American ancestry was strongly associated with increased risk of MeN. We also identified candidate variants in the OPCML gene, which encodes a protein that binds opioid receptors, that were associated with ~sixfold reduced odds of MeN (allele frequency 0.029 in controls and 0.005 in cases, OR = 0.16; P = 4 × 10-8). Sugarcane workers with the protective OPCML variants had markedly increased urine osmolality suggesting greater ability to defend against hypovolemia. Experiments with Opcml knock-out mice revealed roles for OPCML in fluid balance and temperature regulation consistent with our findings in humans. Our data suggest that heritable differential sensitivity to heat stress and dehydration contributes to high rates of kidney disease in Central America.
Keywords: Mesoamerican; OPCML; genetics; kidney disease.
Conflict of interest statement
Competing interests statement:The authors declare no competing interest.
Figures



Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2022 Sep 15;9:CD006332. doi: 10.1002/14651858.CD006332.pub4. PMID: 29869799 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Clinical symptoms, signs and tests for identification of impending and current water-loss dehydration in older people.Cochrane Database Syst Rev. 2015 Apr 30;2015(4):CD009647. doi: 10.1002/14651858.CD009647.pub2. Cochrane Database Syst Rev. 2015. PMID: 25924806 Free PMC article.
Cited by
-
Genetic Factors Related to the Development or Progression of Mesoamerican Endemic Nephropathy.Int J Mol Sci. 2025 May 8;26(10):4486. doi: 10.3390/ijms26104486. Int J Mol Sci. 2025. PMID: 40429630 Free PMC article. Review.
References
-
- Cohen J., Mesoamerica’s mystery killer. Science 344, 143–147 (2014). - PubMed
-
- Ordunez P., et al. , The epidemic of chronic kidney disease in Central America. Lancet Glob. Health 2, e440–e441 (2014). - PubMed
-
- Johnson R. J., Wesseling C., Newman L. S., Chronic kidney disease of unknown cause in agricultural communities. N. Engl. J. Med. 380, 1843–1852 (2019). - PubMed
-
- Chatterjee R., Occupational hazard. Science 352, 24–27 (2016). - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases